兔抗MTARC1多克隆抗體

Background:

As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively.

Applications:

ELISA, WB, IHC

Name of antibody:

MTARC1

Immunogen:

Synthetic peptide of human MTARC1

Full name:

mitochondrial amidoxime reducing component 1

Synonyms:

MARC1; MOSC1

SwissProt:

Q5VT66

IHC positive control:

Human gasrtic cancer and Human thyroid cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

37 kDa

WB Positive control:

Human normal liver tissue

WB Recommended dilution:

200-1000